Aarti Drugs Limited — Important, 16-11-2024: General Updates

Manufacturing at the T-150 unit in Tarapur, Maharashtra, has successfully resumed following compliance with the necessary recommendations from the Directorate of Industrial Safety and Health (DISH). This restoration follows a previous conditional restart directive from the Maharashtra Pollution Control Board (MPCB). Notably, there has been no material impact on the company's financials or operational capabilities during this period. This development indicates a positive outlook for the continuity of production and aligns with the company’s operational stability moving forward. Investors should watch closely for any further updates regarding production levels and overall performance.